NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
29 hedge funds and large institutions have $2.76M invested in Navidea Biopharmaceuticals Inc. in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 3 closing their positions.
Holders
29
Holders Change
-2
Holders Change %
-6.45%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
6
Reduced
9
Closed
3
Calls
$250K
Puts
$619K
Net Calls
-$369K
Net Calls Change
-$188K
Top Buyers
Top Sellers
| 1 |
1
Two Sigma Advisers
New York
|
$170K |
| 2 |
2
Two Sigma Investments
New York
|
$119K |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$74K |
| 4 |
ACM
4
Allred Capital Management
Dallas,
Texas
|
$114K |
| 5 |
5
Morgan Stanley
New York
|
$5K |
